Clinical

  1. Clinical

First Affected person Dosed in Section 2a Medical Trial of a First-in-Class Regenerative Cell Remedy for Sufferers with Finish-Stage Liver Illness

PITTSBURGH, April 2, 2024. LyGenesis, a clinical-stage biotechnology firm growing cell therapies for big unmet medical wants, introduced right this moment that the primary affected person has been dosed of their Section 2a scientific trial evaluating their first-in-class allogenic regenerative cell remedy transplanted into sufferers’ lymph nodes as a possible remedy for […]
Written by
  1. Clinical

Tonix Prescription drugs Receives Uncommon Pediatric Illness Designation from the FDA for TNX-2900 for the Therapy of Prader-Willi Syndrome

CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) — Tonix Prescription drugs Holding Corp. (Nasdaq: TNXP) (Tonix or the Firm), a biopharmaceutical firm with marketed merchandise and a pipeline of growth candidates, as we speak introduced the U.S. Meals and Drug Administration (FDA) has granted Uncommon Pediatric Illness Designation to TNX-2900* (intranasal potentiated oxytocin), a proprietary […]
Written by
  1. Clinical

Constructive Interim Part I Outcomes of Zolmitriptan Transdermal Microporation System for the Therapy of Acute Migraine

SAN DIEGO, March 29, 2024. PassPort Applied sciences, Inc. (PPTI), based mostly in San Diego, a clinical-stage drug and medical machine growth firm, in the present day introduced optimistic interim outcomes from the Part 1 (Half A) scientific trial of Zolmitriptan PassPort using its proprietary transdermal microporation system for the remedy of acute migraine. Zolmitriptan […]
Written by
  1. Clinical

Johnson & Johnson’s Nipocalimab Granted U.S. FDA Quick Observe Designation to Cut back the Threat of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) in Alloimmunized Pregnant Adults

SPRING HOUSE, Pa. March 26, 2024 – Johnson & Johnson introduced right now that the U.S. Meals and Drug Administration (FDA) has granted Quick Observe designation (FTD) for nipocalimab to cut back the chance of FNAIT in alloimmunizeda pregnant adults throughout their present being pregnant. FNAIT is a uncommon and extreme situation that happens when […]
Written by
  1. Clinical

Invivyd Publicizes FDA Authorization for Emergency Use of Pemgarda (Previously VYD222) for Pre-Publicity Prophylaxis (PrEP) of COVID-19

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical firm on a mission to guard the weak from severe viral infectious ailments, as we speak introduced that Pemgarda™ (pemivibart), previously VYD222, a half-life prolonged monoclonal antibody (mAb), has acquired emergency use authorization (EUA) from the U.S. Meals and Drug Administration […]
Written by
  1. Clinical

Lisata Therapeutics Pronounces U.S. FDA Uncommon Pediatric Illness Designation Granted to LSTA1 for the Therapy of Osteosarcoma

BASKING RIDGE, N.J., March 21, 2024. Lisata Therapeutics, Inc. (“Lisata” or the “Firm”), a clinical-stage pharmaceutical firm growing progressive therapies for the remedy of superior strong tumors and different severe illnesses, at present introduced that the U.S. Meals and Drug Administration (the “FDA”) has granted Uncommon Pediatric Illness Designation (“RPDD”) to LSTA1, the Firm’s lead […]
Written by
  1. Clinical

Invoice & Melinda Gates Medical Analysis Institute Initiates Part 3 Scientific Trial of Tuberculosis Vaccine Candidate

CAMBRIDGE, Mass., March 19, 2024. The Invoice & Melinda Gates Medical Analysis Institute (Gates MRI) right now introduced {that a} Part 3 scientific trial to evaluate the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, the place TB takes a heavy toll. If proven to […]
Written by
  1. Clinical

Repurposed Drug Fenoprofen Exhibits Promise Towards Endometriosis-Associated Ache in Animal Mannequin

March 18, 2024 — Fenoprofen, a nonsteroidal anti-inflammatory drug (NSAID), efficiently alleviated ache and irritation in a rodent mannequin of endometriosis, in response to researchers funded by the Nationwide Institutes of Well being (NIH). They selected the drug after utilizing a pc algorithm to guage practically 1,300 current compounds for his or her skill to […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Constructive Outcomes from Part 3 BouNDless Trial of Investigational ND0612 in Folks with Parkinson’s Illness Experiencing Motor Fluctuation

JERSEY CITY, N.J., March 18, 2024. Mitsubishi Tanabe Pharma America, Inc. (MTPA) in the present day introduced the publication of leads to The Lancet Neurology from the pivotal, Part 3 BouNDless trial (NCT04006210) evaluating the efficacy, security and tolerability of investigational ND0612 – a steady, 24 hours/day subcutaneous (SC) infusion of liquid levodopa/carbidopa (LD/CD) – […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Phase 2 Spring Trial Of LHP588, Treatment For P. Gingivalis-positive Alzheimer’s Disease Proceeds

SAN FRANCISCO, Nov. 16, 2023. Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of Alzheimer’s and other diseases of aging, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for LHP588, the company’s next-generation gingipain inhibitor, for the treatment of P. gingivalis-positive […]
Written by

Good Reads

New tentative approval for Alembic drug dabigatran etexilate mesylate

New patent for Vanda Pharms drug HETLIOZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […]
Written by

A proteome-wide yeast degron collection for the dynamic study of protein function

Genome-wide collections of yeast strains, known as libraries, revolutionized the way systematic studies are carried out. Specifically, libraries that involve a cellular perturbation, such as the deletion collection, have facilitated key biological discoveries. However, short-term rewiring and long-term accumulation of suppressor mutations often obscure the functional consequences of such perturbations. We present the AID library […]
Written by

Worlwide

New tentative approval for Alembic drug dabigatran etexilate mesylate

New patent for Vanda Pharms drug HETLIOZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […]
Written by

A proteome-wide yeast degron collection for the dynamic study of protein function

Genome-wide collections of yeast strains, known as libraries, revolutionized the way systematic studies are carried out. Specifically, libraries that involve a cellular perturbation, such as the deletion collection, have facilitated key biological discoveries. However, short-term rewiring and long-term accumulation of suppressor mutations often obscure the functional consequences of such perturbations. We present the AID library […]
Written by

Columbia Climate School Hosts Ninth Annual Sustainability Careers Reception – State of the Planet

Practitioners who attended the 2024 Sustainability Careers Reception. (*See below for names and affiliations) Last month, the Columbia Climate School hosted its ninth annual Sustainability Careers Reception at the Columbia Club in Midtown Manhattan. Thirty-three sustainability professionals and 88 Columbia students from varying backgrounds and degree pursuits gathered to discuss the ever-pressing challenges and real-world […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.